ATE552003T1 - Chinoxalinderivate - Google Patents
ChinoxalinderivateInfo
- Publication number
- ATE552003T1 ATE552003T1 AT03758937T AT03758937T ATE552003T1 AT E552003 T1 ATE552003 T1 AT E552003T1 AT 03758937 T AT03758937 T AT 03758937T AT 03758937 T AT03758937 T AT 03758937T AT E552003 T1 ATE552003 T1 AT E552003T1
- Authority
- AT
- Austria
- Prior art keywords
- chem
- quinoxaline derivatives
- formula
- hydrogen
- independently
- Prior art date
Links
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical class N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical class C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D515/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002313588 | 2002-10-29 | ||
| PCT/JP2003/013707 WO2004039809A1 (ja) | 2002-10-29 | 2003-10-27 | 新規キノキサリノン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE552003T1 true ATE552003T1 (de) | 2012-04-15 |
Family
ID=32211587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03758937T ATE552003T1 (de) | 2002-10-29 | 2003-10-27 | Chinoxalinderivate |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7388010B2 (de) |
| EP (1) | EP1557418B1 (de) |
| JP (1) | JP4492348B2 (de) |
| AT (1) | ATE552003T1 (de) |
| AU (1) | AU2003275681B8 (de) |
| CA (1) | CA2503663C (de) |
| WO (1) | WO2004039809A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005264213A1 (en) * | 2004-05-21 | 2006-01-26 | Msd K.K. | Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| PH12012501003B1 (en) * | 2005-11-16 | 2018-04-06 | Cti Biopharma Corp | Oxygen linked pyrimidine derivatives |
| US10517876B2 (en) | 2005-11-16 | 2019-12-31 | Cti Biopharma Corp. | Oxygen linked pyrimidine derivatives |
| US8884024B1 (en) * | 2013-09-25 | 2014-11-11 | Titan Chemicals Limited | Process for preparing benzisothiazolinones |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69839338T2 (de) | 1997-02-05 | 2008-07-10 | Warner-Lambert Company Llc | Pyrido (2,3-d) pyrimidine und 4-amino-pyrimidine als inhibitoren der zellulären proliferation |
| EP1295878B1 (de) | 2000-06-30 | 2004-09-15 | Banyu Pharmaceutical Co., Ltd. | Pyrazinonderivate |
| JP2002220338A (ja) * | 2001-01-26 | 2002-08-09 | Banyu Pharmaceut Co Ltd | ビアリールウレア化合物又はその塩を有効成分として含有するＣｄｋ４及び／又はＣｄｋ６阻害剤 |
-
2003
- 2003-10-27 US US10/532,677 patent/US7388010B2/en not_active Expired - Fee Related
- 2003-10-27 JP JP2004548041A patent/JP4492348B2/ja not_active Expired - Fee Related
- 2003-10-27 CA CA2503663A patent/CA2503663C/en not_active Expired - Fee Related
- 2003-10-27 AU AU2003275681A patent/AU2003275681B8/en not_active Ceased
- 2003-10-27 AT AT03758937T patent/ATE552003T1/de active
- 2003-10-27 EP EP03758937A patent/EP1557418B1/de not_active Expired - Lifetime
- 2003-10-27 WO PCT/JP2003/013707 patent/WO2004039809A1/ja not_active Ceased
-
2008
- 2008-04-21 US US12/081,773 patent/US20090137597A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004039809A1 (ja) | 2004-05-13 |
| CA2503663A1 (en) | 2004-05-13 |
| CA2503663C (en) | 2010-05-11 |
| US20090137597A1 (en) | 2009-05-28 |
| AU2003275681B8 (en) | 2009-03-26 |
| EP1557418A4 (de) | 2008-04-16 |
| AU2003275681B2 (en) | 2009-03-12 |
| EP1557418A1 (de) | 2005-07-27 |
| AU2003275681A1 (en) | 2004-05-25 |
| EP1557418B1 (de) | 2012-04-04 |
| US20060019959A1 (en) | 2006-01-26 |
| JPWO2004039809A1 (ja) | 2006-03-02 |
| JP4492348B2 (ja) | 2010-06-30 |
| US7388010B2 (en) | 2008-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26512A1 (es) | Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| NL300927I1 (nl) | tivozanib of een zout of hydraat ervan, in het bijzonder het hydrochloride-monohydraat | |
| NO953305D0 (no) | Antranilsyrederivat | |
| DE69720773D1 (de) | SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER | |
| MXPA06001274A (es) | Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio. | |
| CY1113118T1 (el) | Παραγωγα πυριμιδινης | |
| CY1106969T1 (el) | Αναστολεις dpp-iv | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| CY1111816T1 (el) | Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου | |
| ATE237612T1 (de) | Benzofuranderivate | |
| TW200420545A (en) | 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives | |
| MXPA03011682A (es) | Derivados sustituidos de n-acil -anilina, su preparacion y su uso como medicamento. | |
| NO944371D0 (no) | Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning | |
| ATE552003T1 (de) | Chinoxalinderivate | |
| ATE374189T1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| DE60239491D1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
| EP1431293A4 (de) | Wasserlösliche phenylpyridazinderivate und diese enthaltende arzneimittel | |
| DE69231244D1 (de) | Pyrazolothiazolopyrimidin-derivate | |
| DK1433480T3 (da) | Lægemiddel indeholdende pyrimidin-derivat | |
| ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
| ATE268769T1 (de) | Pyrimidinderivate mit antitumor-wirkung | |
| UA89970C2 (ru) | Гетероциклические соединения и активаторы рецептора тромбопоэтина |